These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 33501810)
1. [Correlation between gut microbiota and liver biochemical indicators in patients with chronic hepatitis B]. Zhao Z; Qin S; Wang L; Li L; Liu Y; Deng L; Zou Z Sheng Wu Gong Cheng Xue Bao; 2021 Jan; 37(1):301-311. PubMed ID: 33501810 [TBL] [Abstract][Full Text] [Related]
2. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845 [TBL] [Abstract][Full Text] [Related]
4. Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients. Wang J; Wang Y; Zhang X; Liu J; Zhang Q; Zhao Y; Peng J; Feng Q; Dai J; Sun S; Zhao Y; Zhao L; Zhang Y; Hu Y; Zhang M Front Microbiol; 2017; 8():2222. PubMed ID: 29180991 [TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis. Shu W; Shanjian C; Jinpiao L; Qishui O Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600 [TBL] [Abstract][Full Text] [Related]
6. Modulation of bile acid profile by gut microbiota in chronic hepatitis B. Wang X; Chen L; Wang H; Cai W; Xie Q J Cell Mol Med; 2020 Feb; 24(4):2573-2581. PubMed ID: 31925905 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response. Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112 [TBL] [Abstract][Full Text] [Related]
8. The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection. Yang R; Xu Y; Dai Z; Lin X; Wang H J Immunol Res; 2018; 2018():2361963. PubMed ID: 30148173 [TBL] [Abstract][Full Text] [Related]
9. The role of gut microbiota in hepatitis B disease progression and treatment. Chen B; Huang H; Pan CQ J Viral Hepat; 2022 Feb; 29(2):94-106. PubMed ID: 34415656 [TBL] [Abstract][Full Text] [Related]
10. Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions. Li YG; Yu ZJ; Li A; Ren ZG World J Gastroenterol; 2022 Jul; 28(28):3555-3572. PubMed ID: 36161048 [TBL] [Abstract][Full Text] [Related]
11. Microbial Community of Healthy Thai Vegetarians and Non-Vegetarians, Their Core Gut Microbiota, and Pathogen Risk. Ruengsomwong S; La-Ongkham O; Jiang J; Wannissorn B; Nakayama J; Nitisinprasert S J Microbiol Biotechnol; 2016 Oct; 26(10):1723-1735. PubMed ID: 27381339 [TBL] [Abstract][Full Text] [Related]
12. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease. Lin MJ; Su TH; Chen CC; Wu WK; Hsu SJ; Tseng TC; Liao SH; Hong CM; Yang HC; Liu CJ; Wu MS; Kao JH Gut Pathog; 2023 May; 15(1):24. PubMed ID: 37218009 [TBL] [Abstract][Full Text] [Related]
13. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection. Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895 [TBL] [Abstract][Full Text] [Related]
14. [Effective antiviral therapy with entecavir in chronic hepatitis B virus carriers]. Yan C; Yao Y; Mao X Zhonghua Gan Zang Bing Za Zhi; 2014 Dec; 22(12):900-3. PubMed ID: 25654282 [TBL] [Abstract][Full Text] [Related]
15. Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project. Ling Z; Liu X; Cheng Y; Jiang X; Jiang H; Wang Y; Li L Sci Rep; 2015 Nov; 5():17098. PubMed ID: 26606973 [TBL] [Abstract][Full Text] [Related]
16. Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases. Wu L; Pan Q; Wu G; Qian L; Zhang J; Zhang L; Fang Q; Zang G; Wang Y; Lau G; Li H; Jia W Sci Rep; 2017 Nov; 7(1):16482. PubMed ID: 29184085 [TBL] [Abstract][Full Text] [Related]
17. [Long-term prognosis and quality of life of survivors with hepatitis B virus-related acute-on-chronic liver failure]. Zhu CY; Lu GT; Qi TT; He QJ; Chen YP; Wen WQ; Zhou FY; Chen JJ Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):736-741. PubMed ID: 29997098 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Biejiajian Pill on Intestinal Microbiota in Patients with Hepatitis B Cirrhosis/Liver Fibrosis: A Randomized Double-Blind Controlled Trial. Chi X; Cheng DY; Sun X; Liu SA; Wang RB; Chen Q; Xing HC Chin J Integr Med; 2023 Sep; 29(9):771-781. PubMed ID: 37222832 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis]. Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639 [TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]